Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TroVax +/- GM-CSF in Hormone Refractory Prostate Cancer
NCT00448409Phase 2Completed
- Sponsor
- Houston Methodist Research Institute
- Start
- May 2006
- Primary completion
- Apr 2007
- Modality
- Oncolytic Viruses, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of MVA-5T4 in prostate cancer (PCa), sponsored by Houston Methodist Research Institute. Started May 2006; status: completed.
02
Drugs
MVA-5T4
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00448409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00448409.